{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T20:40:18Z","timestamp":1717792818651},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.gyobfe.2016.02.016","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T10:16:40Z","timestamp":1459160200000},"page":"211-217","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancer du sein et trisomie 21\u00a0: une anomalie g\u00e9n\u00e9tique qui prot\u00e8ge contre le cancer du sein\u00a0?"],"prefix":"10.1016","volume":"44","author":[{"given":"C.","family":"Martel-Billard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cordier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Tomasetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"J\u00e9gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mathelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2016.02.016_bib0315","first-page":"256","article-title":"Mongolism; a chromosomal disease (trisomy)","volume":"143","author":"Lejeune","year":"1959","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0320","first-page":"25","article-title":"Incidence and mortality of Down syndrome","volume":"2","author":"Merrick","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0325","first-page":"105","article-title":"Molecular mapping of the Down syndrome phenotype","volume":"360","author":"Korenberg","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0330","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with Down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0335","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ijc.21518","article-title":"Cancer incidence of persons with Down syndrome in Finland: a population-based study","volume":"118","author":"Patja","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0340","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2788.2006.00862.x","article-title":"The profile and incidence of cancer in Down syndrome","volume":"51","author":"Sullivan","year":"2007","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0345","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.semcancer.2008.03.020","article-title":"Carcinogenesis in Down syndrome: what can be learned from trisomy 21?","volume":"18","author":"Satge","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.0.CO;2-M","article-title":"A tumor profile in Down syndrome","volume":"78","author":"Satge","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0355","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-0004.2010.01521.x","article-title":"Down syndrome patients are less likely to develop some (but not all) malignant solid tumours","volume":"79","author":"Satge","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France over the 1980\u20132012\u00a0period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0365","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1051\/medsci\/2005212175","article-title":"Risk factors and risk reduction of breast cancer","volume":"21","author":"Nkondjock","year":"2005","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0370","first-page":"1239","article-title":"Breast cancer in women with trisomy 21","volume":"185","author":"Satge","year":"2001","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0375","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0021-9681(68)90061-1","article-title":"Down's syndrome: variation of leukemia occurrence in institutionalized populations","volume":"21","author":"Jackson","year":"1968","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0380","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1469-8749.1982.tb13702.x","article-title":"Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976","volume":"24","author":"Scholl","year":"1982","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0385","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(02)08092-3","article-title":"Mortality associated with Down's syndrome in the USA from 1983\u00a0to 1997: a population-based study","volume":"359","author":"Yang","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1651-2227.1978.tb17815.x","article-title":"Follicular development in ovaries of children with Down's syndrome","volume":"67","author":"Hojager","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0395","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jmg.26.5.294","article-title":"Fertility in a male with trisomy 21","volume":"26","author":"Sheridan","year":"1989","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.gyobfe.2016.02.016_bib0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2788.1995.tb00481.x","article-title":"Menopause in women with learning disabilities","volume":"39","author":"Carr","year":"1995","journal-title":"J Intellect Disabil Res"},{"issue":"3","key":"10.1016\/j.gyobfe.2016.02.016_bib0405","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2788.1997.tb00706.x","article-title":"Early menopause in women with Down's syndrome","volume":"41","author":"Schupf","year":"1997","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0410","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down's syndrome","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0415","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0028-2243(88)90048-2","article-title":"Menarche, menstruation, sexual relations and contraception of adolescent females with Down syndrome","volume":"27","author":"Goldstein","year":"1988","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpag.2009.04.005","article-title":"Gynecologic issues of adolescents with Down syndrome, autism, and cerebral palsy","volume":"23","author":"Burke","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0425","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/j.ridd.2013.09.021","article-title":"Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader-Willi syndrome","volume":"34","author":"Nordstrom","year":"2013","journal-title":"Res Dev Disabil"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0430","doi-asserted-by":"crossref","first-page":"e28618","DOI":"10.1371\/journal.pone.0028618","article-title":"Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down's syndrome","volume":"6","author":"Phillips","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0435","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-3016.2000.00252.x","article-title":"Survival of infants born with Down's syndrome: 1980\u201396","volume":"14","author":"Leonard","year":"2000","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0440","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer du sein en France entre 1980\u00a0et 2012. Partie 1 - tumeurs solides","first-page":"122","author":"Binder Foucart","year":"2013"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0445","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10038-006-0395-4","article-title":"Molecular cytogenetic characteristics of Down syndrome newborns","volume":"51","author":"Amiel","year":"2006","journal-title":"J Hum Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cancergencyto.2009.03.003","article-title":"Telomere aggregates in trisomy 21\u00a0amniocytes","volume":"195","author":"Hadi","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0455","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/(SICI)1096-8628(19970120)68:2<147::AID-AJMG5>3.0.CO;2-M","article-title":"Increased low-level chromosome 21\u00a0mosaicism in older individuals with Down syndrome","volume":"68","author":"Jenkins","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0460","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajmg.1320450513","article-title":"Age-associated chromosome 21\u00a0loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease","volume":"45","author":"Percy","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0465","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1365-2141.2012.09224.x","article-title":"High frequency of copy number alterations in myeloid leukaemia of Down syndrome","volume":"158","author":"Blink","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0470","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gyobfe.2016.02.016_bib0475","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.3233\/JAD-2010-100351","article-title":"Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia","volume":"20","author":"Coskun","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0480","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/j.1471-4159.2009.06294.x","article-title":"Increased lipid peroxidation in Down's syndrome mouse models","volume":"110","author":"Ishihara","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0485","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1179\/135100006X101039","article-title":"Reactive oxygen species generation in gingival fibroblasts of Down syndrome patients detected by electron spin resonance spectroscopy","volume":"11","author":"Komatsu","year":"2006","journal-title":"Redox Rep"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0490","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.mrfmmm.2007.07.010","article-title":"DNA damage and repair in children with Down's syndrome","volume":"637","author":"Morawiec","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0495","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.neurobiolaging.2006.03.008","article-title":"Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease","volume":"28","author":"Zana","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0500","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1203\/00006450-198004000-00015","article-title":"Decreased repair of X-ray induced DNA single-strand breaks in lymphocytes in Down's syndrome","volume":"14","author":"Athanasiou","year":"1980","journal-title":"Pediatr Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0505","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0921-8777(98)00042-1","article-title":"Defective repair of oxidative damage in mitochondrial DNA in Down's syndrome","volume":"409","author":"Druzhyna","year":"1998","journal-title":"Mutat Res"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0047-6374(97)00121-8","article-title":"Trisomy 21\u00a0and accelerated aging: DNA-repair parameters in peripheral lymphocytes of Down's syndrome patients","volume":"100","author":"Raji","year":"1998","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0515","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1352\/2009.114.100-109","article-title":"T lymphocyte maturation is impaired in healthy young individuals carrying trisomy 21 (Down syndrome)","volume":"114","author":"Guazzarotti","year":"2009","journal-title":"Am J Intellect Dev Disabil"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0520","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archinte.163.6.705","article-title":"Mortality and cancer incidence among individuals with Down syndrome","volume":"163","author":"Hill","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0525","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0165-4608(02)00596-4","article-title":"Trisomy 21\u00a0as the only recurrent chromosomal anomaly in a clinically aggressive ovarian carcinoma","volume":"138","author":"Faruqi","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0530","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0165-4608(96)00351-2","article-title":"Acute lymphoblastic leukemia and chromosome 21","volume":"94","author":"Berger","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0535","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00277-005-1099-0","article-title":"Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2235\u00a0patients","volume":"84","author":"Bacher","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0540","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature06446","article-title":"Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome","volume":"451","author":"Sussan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0545","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.pharmtox.40.1.519","article-title":"The PAS superfamily: sensors of environmental and developmental signals","volume":"40","author":"Gu","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0550","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1128\/MCB.17.9.4933","article-title":"The murine Sim-2\u00a0gene product inhibits transcription by active repression and functional interference","volume":"17","author":"Moffett","year":"1997","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0555","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/carcin\/bgl122","article-title":"Inhibition of breast cancer growth and invasion by single-minded 2s","volume":"28","author":"Kwak","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0560","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1038\/sj.emboj.7601825","article-title":"The candidate tumor suppressor BTG3\u00a0is a transcriptional target of p53\u00a0that inhibits E2F1","volume":"26","author":"Ou","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0565","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1242\/jcs.02778","article-title":"APRO4\u00a0negatively regulates Src tyrosine kinase activity in PC12\u00a0cells","volume":"119","author":"Rahmani","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0570","first-page":"173","article-title":"Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells","volume":"14","author":"Yu","year":"2008","journal-title":"Gene Expr"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0575","first-page":"773","article-title":"Trefoil factor 1 (pS2\/TFF1), a peptide with numerous functions","volume":"92","author":"Mathelin","year":"2005","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0580","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb200108056","article-title":"The trefoil factor 1\u00a0participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis","volume":"157","author":"Bossenmeyer-Pourie","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0585","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.ejhg.5200721","article-title":"High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours","volume":"9","author":"Zorick","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0590","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ni966","article-title":"The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin","volume":"4","author":"Ryeom","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0595","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nature08062","article-title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1","volume":"459","author":"Baek","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0600","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.morpho.2012.10.001","article-title":"Trisomy 21\u00a0and cancers","volume":"96","author":"Ayed","year":"2012","journal-title":"Morphologie"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0605","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ijc.20532","article-title":"Down's syndrome protects against breast cancer: is a constitutional cell microenvironment the key?","volume":"113","author":"Benard","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0610","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.freeradbiomed.2006.03.015","article-title":"Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth","volume":"41","author":"Weydert","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0615","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1034\/j.1600-0773.2001.d01-168.x","article-title":"Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome","volume":"89","author":"Torsdottir","year":"2001","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.gyobfe.2016.02.016_bib0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958916300339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958916300339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T20:53:53Z","timestamp":1536872033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958916300339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1297958916300339"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2016.02.016","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer du sein et trisomie 21\u00a0: une anomalie g\u00e9n\u00e9tique qui prot\u00e8ge contre le cancer du sein\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gyobfe.2016.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}